Bristol-Myers Squibb Company (BMY)

Operating profit margin

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Operating income (ttm) US$ in thousands -12,354,000 -11,456,000 -11,502,000 -11,251,000 -9,504,000 -10,337,000 -10,597,000 -9,851,000 -10,280,000 -12,331,000 -12,539,000 -14,016,000 -15,487,000 -1,800,000 -2,410,000 -3,043,000 -3,317,000 -6,022,000 1,007,000 4,789,000
Revenue (ttm) US$ in thousands 48,300,000 47,435,000 46,509,000 45,534,000 45,006,000 44,935,000 45,187,000 45,848,000 46,159,000 46,738,000 47,144,000 46,960,000 46,385,000 45,468,000 44,384,000 42,810,000 42,518,000 39,395,000 34,862,000 31,006,000
Operating profit margin -25.58% -24.15% -24.73% -24.71% -21.12% -23.00% -23.45% -21.49% -22.27% -26.38% -26.60% -29.85% -33.39% -3.96% -5.43% -7.11% -7.80% -15.29% 2.89% 15.45%

December 31, 2024 calculation

Operating profit margin = Operating income (ttm) ÷ Revenue (ttm)
= $-12,354,000K ÷ $48,300,000K
= -25.58%

The operating profit margin of Bristol-Myers Squibb Company has shown a consistent decline over the past few years, indicating a downward trend in the company's profitability from March 31, 2020, to December 31, 2024. The operating profit margin started at 15.45% in March 2020 but steadily decreased, turning negative by September 2020 and stayed negative throughout the following years.

The decline in operating profit margin can indicate challenges such as decreasing sales, increasing operating expenses, or both. A negative operating profit margin suggests that the company's operating expenses exceed its gross profit, leading to operating losses.

It is crucial for Bristol-Myers Squibb Company to closely monitor and address the factors contributing to this declining trend in operating profit margin to sustain its financial health and long-term success. Further analysis of the company's operational efficiency, cost management strategies, revenue streams, and market competition may be necessary to identify opportunities for improvement.


See also:

Bristol-Myers Squibb Company Operating Profit Margin (Quarterly Data)